Vimarsana
Biggest News Aggregation in the World

Page 23 - Manufacturing Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manufacturing Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manufacturing Practice Today - Breaking & Trending Today

AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany - Vimarsana News

AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.) ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (" AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s (" Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (" CC Pharma"), have entered into a strategic agreement (the " Co-Promotion Agreement") covering joint marketing of sales for Aphria brand medical cannabis products for the German market. The Co-Promotion Agreement is a collaboration contract between AMP and ...

/R E P E A T -- AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany/ - Vimarsana News

/R E P E A T -- AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany/

Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.) ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (" AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s (" Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (" CC Pharma"), have entered into a strategic agreement (the " Co-Promotion Agreement") covering joint marketing of sales for Aphria brand medical cannabis products for the German market. The Co-Promotion Agreement is a collaboration contract between AMP and ...

Top 10 Most-Cited MHRA GMP Inspection Deficiencies By AnnexChapter In 2019 - Vimarsana News

Top 10 Most-Cited MHRA GMP Inspection Deficiencies By AnnexChapter In 2019

In Part 1 of this two-part article, we evaluated the U.K. Medicines and Healthcare products Regulatory Agency’s GMP inspection data for 2019...

LASA Received WHO Nod for its unit Located at Khed (Ratnagiri) - Vimarsana News

LASA Received WHO Nod for its unit Located at Khed (Ratnagiri)

LASA Received WHO Nod for its unit Located at Khed (Ratnagiri)

LASA receives WHO Nod for its Khed Unit in Ratnagiri - Vimarsana News

LASA receives WHO Nod for its Khed Unit in Ratnagiri

LASA receives WHO Nod for its Khed Unit in Ratnagiri ANI | Updated: Jan 12, 2021 18:19 IST "WHO Good Manufacturing Practice certificate can be obtained by constant efforts towards improving the quality assurance as well as implementation of various systems on place, though we already have GMP for our other major units, we are also proud to receive this recognition for our Unit Located in Khed with the efforts of our Hardworking Team," said Dr Omkar Herlekar, Chairman - Lasa Supergenerics Limited, commenting on the development. WHO GMP covers all aspects o...

Source: aninews.in